Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

International severe asthma registry (ISAR): protocol for a global registry

Research output: Contribution to journalJournal articleResearchpeer-review

  1. DEBATE-statistical analysis plans for observational studies

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The "RCT augmentation": a novel simulation method to add patient heterogeneity into phase III trials

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Trial Sequential Analysis in systematic reviews with meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Physiological abnormalities in patients admitted with acute exacerbation of COPD: an observational study with continuous monitoring

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Chronic rhinosinusitis in COPD: A prevalent but unrecognized comorbidity impacting health related quality of life

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Systematic Assessment of Difficult-to-Treat Asthma: Principles and Perspectives

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Airway hyperresponsiveness to mannitol improves in both type 2 high and type 2 low asthma after specialist management

    Research output: Contribution to journalJournal articleResearchpeer-review

  • J Mark FitzGerald
  • Trung N Tran
  • Marianna Alacqua
  • Alan Altraja
  • Vibeke Backer
  • Leif Bjermer
  • Unnur Bjornsdottir
  • Arnaud Bourdin
  • Guy Brusselle
  • Lakmini Bulathsinhala
  • John Busby
  • Giorgio W Canonica
  • Victoria Carter
  • Isha Chaudhry
  • You Sook Cho
  • George Christoff
  • Borja G Cosio
  • Richard W Costello
  • Neva Eleangovan
  • Peter G Gibson
  • Liam G Heaney
  • Enrico Heffler
  • Mark Hew
  • Naeimeh Hosseini
  • Takashi Iwanaga
  • David J Jackson
  • Rupert Jones
  • Mariko S Koh
  • Thao Le
  • Lauri Lehtimäki
  • Dora Ludviksdottir
  • Anke H Maitland-van der Zee
  • Andrew Menzies-Gow
  • Ruth B Murray
  • Nikolaos G Papadopoulos
  • Luis Perez-de-Llano
  • Matthew Peters
  • Paul E Pfeffer
  • Todor A Popov
  • Celeste M Porsbjerg
  • Chris A Price
  • Chin K Rhee
  • Mohsen Sadatsafavi
  • Yuji Tohda
  • Eileen Wang
  • Michael E Wechsler
  • James Zangrilli
  • David B Price
View graph of relations

BACKGROUND: Severe asthma exerts a disproportionately heavy burden on patients and health care. Due to the heterogeneity of the severe asthma population, many patients need to be evaluated to understand the clinical features and outcomes of severe asthma in order to facilitate personalised and targeted care. The International Severe Asthma Registry (ISAR) is a multi-country registry project initiated to aid in this endeavour.

METHODS: ISAR is a multi-disciplinary initiative benefitting from the combined experience of the ISAR Steering Committee (ISC; comprising 47 clinicians and researchers across 29 countries, who have a special interest and/or experience in severe asthma management or establishment and maintenance of severe asthma registries) in collaboration with scientists and experts in database management and communication. Patients (≥18 years old) receiving treatment according to the 2018 definitions of the Global Initiative for Asthma (GINA) Step 5 or uncontrolled on GINA Step 4 treatment will be included. Data will be collected on a core set of 95 variables identified using the Delphi method. Participating registries will agree to provide access to and share standardised anonymous patient-level data with ISAR. ISAR is a registered data source on the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance. ISAR's collaborators include Optimum Patient Care, the Respiratory Effectiveness Group (REG) and AstraZeneca. ISAR is overseen by the ISC, REG, the Anonymised Data Ethics & Protocol Transparency Committee and the ISAR operational committee, ensuring the conduct of ethical, clinically relevant research that brings value to all key stakeholders.

CONCLUSIONS: ISAR aims to offer a rich source of real-life data for scientific research to understand and improve disease burden, treatment patterns and patient outcomes in severe asthma. Furthermore, the registry will provide an international platform for research collaboration in respiratory medicine, with the overarching aim of improving primary and secondary care of adults with severe asthma globally.

Original languageEnglish
JournalBMC Medical Research Methodology
Volume20
Issue number1
Pages (from-to)212
ISSN1471-2288
DOIs
Publication statusPublished - 14 Aug 2020

ID: 60804841